Researchers at Children’s Healthcare of Atlanta and Georgia Tech are testing an AI tool to detect worsening teen mental health online. As concerns grow about the effects of social media on adolescent ...

US measles cases reached 1,842 as of May 7, 2026, marking the highest annual total in 35 years. Pediatric organizations emphasized on-time MMR vaccination to protect infants and vulnerable children.

An international consensus group has recommended renaming PCOS to polyendocrine metabolic ovarian syndrome (PMOS). The new terminology is intended to better reflect the endocrine and metabolic ...

Chronic pediatric skin disorders cause significant stigma, bullying, depression, and suicide risk—conditions often underrecognized and undertreated by physicians. Pediatric patients with chronic skin ...

In a nationwide Finnish cohort of more than 580,000 individuals, later age at ADHD diagnosis was consistently associated with lower GPA at aged 16 years. Individuals diagnosed with ADHD in adolescence ...

Trofinetide offers the first targeted treatment for Rett syndrome, with a new, convenient powdered formulation aimed at significantly reducing adverse effects. Rett syndrome is a severe ...

Cognitive-linguistic deficits in kindergarten—especially in phonological awareness and letter knowledge—strongly predict early-emerging dyslexia by first grade. Specific kindergarten deficits, ...

Data found that mavacamten significantly reduces cardiac obstruction and improves clinical markers in adolescents with symptomatic obstructive hypertrophic cardiomyopathy. In a recent interview with ...

The FDA has updated its approval for 1-mg epinephrine nasal spray, removing the age limit to allow all patients weighing at least 33 lb to access the treatment. In a recent discussion with ...

The FDA has approved once-weekly somapacitan-beco for children aged 2.5 years and older with 3 separate growth indications. The FDA has approved somapacitan-beco (Sogroya; Novo Nordisk) 5 mg, 10 mg, ...

National data suggest universal high ED pediatric readiness may prevent 2,143 child deaths annually at modest per-child cost.

CRL focused on usability, not efficacy or manufacturing: The FDA’s Complete Response Letter for Anaphylm cited deficiencies limited to human factors, labeling, and a single supportive PK study; no CMC ...